A strategy for scalable antibody production: the combination of Escherichia coli expression, translation-enhancing peptide and automated refolding system.

Monoclonal antibodies are essential tools in biological research, diagnostics, and therapeutics. While mammalian expression systems are widely used, microbial hosts such as Escherichia coli offer cost-effective and scalable production of antibody fra…

Preview only. Read the full abstract at the source